DoD Lupus, Transformative Vision Award | W81XWH 21 LRP TVA

Frequently Asked Questions (FAQs): DoD Lupus Research Program Transformative Vision Award (TVA)

What is the Transformative Vision Award (TVA)?

The Department of Defense (DoD) Lupus Research Program (LRP) Transformative Vision Award (TVA) is a discretionary research funding opportunity intended to support unusually bold, high-impact projects that can noticeably improve the day-to-day quality of life for people living with lupus in the near term. A key expectation is translation: the work should move beyond generating knowledge and produce a practical, testable intervention that can be implemented at the individual patient level and/or within the healthcare system.

What kind of impact is the program looking for?

The TVA is explicitly impact-driven. Applicants are expected to describe, in direct and concrete terms, how the proposed intervention would change outcomes that matter to patients and families, and why those changes would be significant. The emphasis is on meaningful, near-term quality-of-life improvement rather than purely descriptive or exploratory research.

Is this a basic science opportunity or a translational/intervention-focused opportunity?

Based on the opportunity description, it is primarily translational and intervention-focused. The central expectation is a practical, testable intervention that can be implemented for patients and/or in care delivery settings. While the approach may be novel or literature-informed, it must be supported by a rigorous rationale and a realistic plan for testing the stated vision.

Does the program allow high-risk, high-reward ideas?

Yes. The TVA is framed as high-risk, high-reward. Ambitious approaches are encouraged as long as they are supported by a credible rationale and a realistic plan to test and achieve the proposed transformative vision.

Are preliminary data required?

Yes. Preliminary data are required, indicating the DoD expects applicants to present early evidence that the proposed approach is feasible and worth scaling into a larger translational effort.

Who can the project help (age groups, populations, or subgroups)?

Projects can target lupus patients of any age. Proposals may address quality-of-life challenges broadly, including issues affecting groups that carry disproportionate health burdens.

What types of outcomes should the intervention aim to improve?

The opportunity emphasizes outcomes that matter to patients and families and that improve day-to-day quality of life. Applicants should articulate how the intervention changes concrete, meaningful outcomes in the near term, rather than focusing only on knowledge generation.

Do projects need to align with a specific focus area?

Yes. Proposed projects must address the FY21 LRP Focus Area specific to the Transformative Vision Award. Applicants should ensure their specific aims match the program priorities for that fiscal year.

Does the project need to be relevant to the military community or the general public?

Yes. The work must be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the broader American public. This reflects a common CDMRP public-purpose requirement.

Are human subjects research and clinical trials allowed?

Yes. The award explicitly allows human subjects research and clinical trials, making it suitable for studies that directly test interventions in people and/or within healthcare delivery settings.

Is animal research permitted under this announcement?

No. Animal research is not permitted under this announcement. Projects must be designed without relying on animal models for proof-of-concept or mechanistic testing within the scope of the funded work.

What level of scientific rigor is expected?

The research strategy is expected to demonstrate a strong grasp of lupus and the specific problems the intervention is meant to address. Reviewers will look for thoughtful justification, careful methodology, and an experimental plan reflecting an in-depth understanding of lupus and the real-world context of lupus care. Approaches can be novel or based on existing literature, but they must be presented with a rigorous rationale (not as purely exploratory or descriptive work).

Is consumer advocate involvement required?

Yes. Authentic consumer advocate involvement is a major requirement. Applications must include one or more consumer advocates as integral members of the research team with ongoing engagement throughout planning and implementation.

What does "authentic" consumer advocate involvement mean for this award?

The program expects consumer advocates to actively shape the research question, contribute to project design, participate in oversight, support recruitment strategies, and assist in evaluation and interpretation. The advocate role is expected to be substantive and ongoing, not symbolic.

Who qualifies as a consumer advocate for this opportunity?

The consumer advocate must be a lupus patient or caregiver who is active in a lupus advocacy organization. The advocate cannot be an employee of any participating organization and is expected to provide independent, objective input focused on patient impact. The advocate should also be familiar with current lupus issues and have enough background or training to contribute meaningfully in a research environment.

Can the same organization employing the research team employ the consumer advocate?

No. The consumer advocate cannot be an employee of any participating organization, based on the requirements described in the opportunity information.

Does the opportunity encourage multi-institutional collaboration?

Yes. The TVA encourages collaboration via a Partnering Principal Investigator (PI) option.

How does the Partnering PI option work?

One PI serves as the Initiating PI and handles most submission-related administration. Up to two additional Partnering PIs can be named. The intent is for each PI to make substantive contributions to the development and core components of the project (for example, the project narrative and statement of work), not simply to be listed.

If funded, how are awards handled for multiple PIs across institutions?

If funded, each PI is named on an individual award within their organization. This structure is intended to formalize shared responsibility across institutions.

What type of funding instrument is used (grant vs. cooperative agreement)?

Awards are issued as assistance agreements. Depending on the anticipated level of DoD involvement during performance, the agreement may be structured as a grant (when no substantial agency involvement is expected) or a cooperative agreement (when substantial involvement is expected, such as agency collaboration or participation). The exact award type is determined during negotiations.

What is the maximum total budget for this award?

The anticipated total cost for the entire period of performance is capped at $2.5 million. While an "award ceiling" field is listed as 0 in the provided listing, the narrative guidance establishes the practical maximum as $2.5 million in total costs.

How many awards are expected to be made?

The program expected to allocate about $2.5 million total to fund approximately one Transformative Vision Award under this FY21 opportunity, indicating a highly competitive, single-award call.

Does the budget need to match the proposed work?

Yes. The budget must be well matched to the work proposed and must comply with the program's funding restrictions (as referenced in the opportunity information).

What is the opportunity number for this funding call?

The opportunity number is W81XWH-21-LRP-TVA.

What was the original closing date for this opportunity?

The original closing date was September 22, 2021.

When were awards expected to be made?

Awards were expected to be made no later than September 30, 2022.

Is funding guaranteed once an application is submitted?

No. Funding availability is contingent on federal appropriations, the number and quality of submissions, and programmatic requirements.

How long were FY21 funds expected to remain available for use?

Funds anticipated for FY21 awards were expected to be FY21 dollars, with availability for use limited by the federal period of availability, noted as expiring for use on September 30, 2027.

Who is eligible to apply?

Eligible applicants were listed as unrestricted, meaning the call was broadly open to many entity types, subject to any additional eligibility clarifications in the full announcement.

What is the core "must-have" feature of a competitive TVA proposal based on this description?

A competitive proposal, as described here, would present a bold but credible intervention concept backed by preliminary data, a rigorous and lupus-informed research strategy, clear near-term quality-of-life impact for patients, alignment with the FY21 LRP TVA Focus Area, relevance to military beneficiaries and/or the broader public, no animal research, and meaningful, ongoing consumer advocate involvement integrated throughout the project.